QR kód

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review

Background: There is a belief that in patients with acromegaly, first-generation somatostatin analogs (SSAs) might improve cardiovascular (CV) structure and function. However, most published clinical trials involved only a few patients and their results are rather variable. We aimed to conduct a sys...

Celý popis

Uloženo v:
Hlavní autoři: Maryam Heidarpour, Davood Shafie, Ashraf Aminorroaya, Nizal Sarrafzadegan, Ziba Farajzadegan, Rasool Nouri, Arash Najimi, Christina Dimopolou, Gunter Stalla
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2019-01-01
Edice:Journal of Research in Medical Sciences
Témata:
acromegaly
cardiomyopathy
growth hormone
receptor
somatostatin
On-line přístup:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=29;epage=29;aulast=Heidarpour
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky